To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-M
Trial details
- Registry ID
- NCT05733780
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as Galactomannan
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| To Evaluate the Safety, Efficacy,and Pharmacokinetics of Orally Administered Prolectin-MNCT05733780 | Bioxytran Inc. | Phase 2 | Unknown | 2023-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |